Red Burner

by Red Supplements · capsule · 90 capsules

  • Off the market since September 2023 (NIH)
  • DSLD label 229173
  • Serving 1 to 2 capsules; amounts per 1 capsule
  • 90 servings

Red Burner by Red Supplements lists 6 ingredients; 6 sit inside a blend without their own amounts. Its current label entered the NIH Dietary Supplement Label Database on July 23, 2020.

What is in Red Burner?

Each row as the label prints it, per serving of 1 capsule. The capsule beside an amount places it among every product in the NIH database that lists the same ingredient: the bar is the middle half of their amounts, the line in it the median, the whiskers the 10th and 90th percentiles; the green tick is the FDA Daily Value and the red dashed tick the adult upper limit (IOM).

Red Burner: Supplement Facts rows against the market (DSLD label 229173, January 2026 release)
IngredientAmount% DVAmong products listing it
Proprietary Blend550 mg
N-Acetyl L-Tyrosinein the blend, no amount given
Caffeine Anhydrousin the blend, no amount given
B-Phenylethylaminein the blend, no amount given
Green Tea extractin the blend, no amount given
Dendrobiumin the blend, no amount given
3,5 Diiodo L-Thyroninein the blend, no amount given

Source: NIH ODS Dietary Supplement Label Database, label 229173 (entered July 23, 2020), version 9.4.0. See the label on DSLD. Amounts are what the maker printed; DSLD does not test products. Daily Values: the FDA's Daily Value page.

Is that a lot?

Every amount on this label with a position sits within the middle 80% of the products that list the same ingredient; 6 ingredients sit inside a blend, so their amounts cannot be compared.

The NIH database records one serving a day from the label's directions; its % Daily Values are for adults and children 4 or more years of age. The directions as printed are further down this page.

The Tolerable Upper Intake Level is the most of a nutrient per day, from food, water and supplements together, that is likely to pose no risk for almost all adults (Institute of Medicine, 2011). It does not apply under medical supervision. This page compares labels; it is not medical advice.

Sources: amounts from the DSLD label; Daily Values from 21 CFR 101.9(c)(8)(iv); adult upper limits from the Institute of Medicine's DRI summary tables (2011). How positions are computed.

Which products have the closest formulas?

1 product lists the very same ingredients; the nearest amounts come first.

Source: ingredient lists of every product's current label in DSLD (version 9.4.0); similarity weights each shared ingredient by how rare it is.

What does the label say about taking it?

Quoted from the label as DSLD transcribed it: the maker's words, including any claim about what the product does, which the FDA has not evaluated and PlainVitamins does not endorse.

Directions
Suggested Use Take 1-2 capsules daily.
Warnings
Do not exceed recommended dose.
Warning: Keep out of reach of children. This product is not intended for anyone under the age of 21.
You must be 21 years of age to purchase this product. Do not take this product if you have prostatic hypertrophy, liver disease, kidney or heart disease.
This product should not be taken by women who are pregnant, nursing, or trying to become pregnant.
Do not take this product if you have been diagnosed with high cholesterol, prostate cancer, testicular cancer or breast cancer. Consult your physician before using any dietary supplement. Notify your doctor and discontinue use if you experience any adverse side effects.

Source: label statements in DSLD label 229173.

What else is on the label?

Other ingredients: Gelatin, Magnesium Stearate, FD&C Red #3.

How many labels does Red Burner have?

One label is on file, entered on July 23, 2020.

  1. Label 229173 (current) Entered July 23, 2020 · off the market September 28, 2023 · 90 capsules

Source: DSLD label entry and market events, version 9.4.0 (labels entered through September 25, 2025).

Who makes it?

The label names Red Supplements, LLC. (distributor), Boise, ID. All Red Supplements products.

Where next?